These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 1666665

  • 21. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
    Benjamin CW, Lin AH, Morris J, Wishka DG, Gorman RR.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
    [Abstract] [Full Text] [Related]

  • 22. The mechanism(s) of the antiaggregatory effects of cryptolepine: the role of cyclic adenosine monophosphate and cellular Ca2+.
    Oyekan AO, Ablordeppey SY.
    Gen Pharmacol; 1993 Mar; 24(2):461-9. PubMed ID: 7683302
    [Abstract] [Full Text] [Related]

  • 23. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675
    [Abstract] [Full Text] [Related]

  • 24. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA, Reimann S, Schrör K.
    Br J Pharmacol; 1999 Jan 15; 126(2):415-20. PubMed ID: 10077233
    [Abstract] [Full Text] [Related]

  • 25. [Effect of nimodipine on the intracellular calcium level and platelet aggregation in ischemic stroke patients].
    Prianikova NA, Dukhanin AS, Stakhovskaia LV, Chekneva NS.
    Biull Eksp Biol Med; 1996 Mar 15; 121(3):317-20. PubMed ID: 8688539
    [No Abstract] [Full Text] [Related]

  • 26. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu, Melkova OM, Karaulov AV, Porodenko NV.
    Biull Eksp Biol Med; 1992 Jun 15; 113(6):606-8. PubMed ID: 1446028
    [Abstract] [Full Text] [Related]

  • 27. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A, Breiter N, Ogawa T, Asai F, Koike H.
    Thromb Haemost; 1996 Nov 15; 76(5):786-90. PubMed ID: 8950791
    [Abstract] [Full Text] [Related]

  • 28. Inhibitory mechanism of cis-polyunsaturated fatty acids on platelet aggregation: the relation with their effects on Ca2+ mobilization, cyclic AMP levels and membrane fluidity.
    Kitagawa S, Kotani K, Kametani F.
    Biochim Biophys Acta; 1990 Aug 13; 1054(1):114-8. PubMed ID: 2166588
    [Abstract] [Full Text] [Related]

  • 29. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
    Lee KS, Khil LY, Chae SH, Kim D, Lee BH, Hwang GS, Moon CH, Chang TS, Moon CK.
    Life Sci; 2006 Feb 02; 78(10):1091-7. PubMed ID: 16153663
    [Abstract] [Full Text] [Related]

  • 30. Surfactin C inhibits platelet aggregation.
    Kim SD, Park SK, Cho JY, Park HJ, Lim JH, Yun HI, Park SC, Lee KY, Kim SK, Rhee MH.
    J Pharm Pharmacol; 2006 Jun 02; 58(6):867-70. PubMed ID: 16734989
    [Abstract] [Full Text] [Related]

  • 31. Na+/H+ exchange in PAF-stimulated platelets.
    Borin ML, Pinelis VG, Azizova OA, Kudinov YV, Markov CM, Cragoe EJ, Khodorov BI.
    J Lipid Mediat; 1989 Jun 02; 1(5):257-72. PubMed ID: 2562435
    [Abstract] [Full Text] [Related]

  • 32. Papaverine inhibits human platelet aggregation induced by ADP.
    Serro-Azul MI, Bydlowski SP, Chamone DA.
    Braz J Med Biol Res; 1992 Jun 02; 25(5):521-8. PubMed ID: 1342229
    [Abstract] [Full Text] [Related]

  • 33. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F, Bachelot C, Molle D, Caen J, Guez D.
    J Cardiovasc Pharmacol; 1993 Jun 02; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC, Huang WH, Shiau CY, Lee AR, Chou TC.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):32-7. PubMed ID: 16457809
    [Abstract] [Full Text] [Related]

  • 35. Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
    Lindgren SH, Andersson TL, Vinge E, Andersson KE.
    Acta Physiol Scand; 1990 Oct 17; 140(2):209-19. PubMed ID: 2176433
    [Abstract] [Full Text] [Related]

  • 36. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
    Kamruzzaman SM, Yayeh T, Ji HD, Park JY, Kwon YS, Lee IK, Kim S, Oh SH, Kim SD, Roh SS, Yun BS, Rhee MH.
    Vascul Pharmacol; 2013 Oct 17; 59(3-4):83-9. PubMed ID: 23872194
    [Abstract] [Full Text] [Related]

  • 37. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
    Azula FJ, Alzola ES, Conde M, Trueba M, Macarulla JM, Marino A.
    Mol Pharmacol; 1996 Aug 17; 50(2):367-79. PubMed ID: 8700145
    [Abstract] [Full Text] [Related]

  • 38. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 17; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 39. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.
    Nakamura T, Uchiyama S, Yamazaki M, Iwata M.
    Thromb Res; 2007 Jun 17; 119(4):511-6. PubMed ID: 17046050
    [Abstract] [Full Text] [Related]

  • 40. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
    Okuma M, Kanaji K, Sensaki S, Uchino H.
    Arzneimittelforschung; 1989 Mar 17; 39(3):372-5. PubMed ID: 2502990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.